论文部分内容阅读
目的本文就米氮平对老年失眠伴抑郁症的疗效及安全性进行了观察和分析。方法就我院2015年01月01日至2015年12月01日就医的90例老年失眠伴抑郁症的患者进行详细的讨论和分析,将其通过随机分类的方式分为干预组和对照组进行治疗观察,分别经由米氮平和常规治疗的方式。结果通过上述实验的对比分析后发现,干预组患者的临床治疗效果明显好于对照组患者,且干预组患者的汉密尔顿抑郁量表评分和副反应量表评分情况均好于对照组患者,两组患者的数据对比具有明显差异(P<0.05),差异具有统计学意义。结论通过上述实验研究结果的对比分析后发现,使用米氮平对老年失眠伴抑郁症的临床效果显著,其不仅能够有效的减轻患者的抑郁症状,而且能够有效的减少副反应的发生。
Objective To investigate the efficacy and safety of mirtazapine in the treatment of depression in elderly patients with insomnia. Methods A total of 90 elderly patients with insomnia and depression treated in our hospital from January 1, 2015 to December 01, 2015 were discussed and analyzed in detail. The patients were randomly divided into intervention group and control group Treatment observation, respectively, by means of mirtazapine and conventional treatment. Results Through the comparative analysis of the above experiments, the clinical treatment effect of the intervention group was significantly better than that of the control group, and the Hamilton Depression Rating Scale and the Side Effects Scale score of the intervention group were better than the control group. The two groups There was significant difference between the data of patients (P <0.05), the difference was statistically significant. Conclusions The comparative analysis of the above experimental results found that the use of mirtazapine in elderly patients with insomnia with significant clinical effect of depression, which not only can effectively reduce the symptoms of depression in patients, and can effectively reduce the incidence of side effects.